Purchase Order 75F40121P00343
- Not listed
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a firm fixed-price purchase order valued at $24,459.12 by a civilian federal agency on May 5, 2015, with an ultimate completion date of June 22, 2015. The contract was not set-aside and was performed in Grand Island, New York. As a leading provider of biomedical research and genetic analysis tools, Life Technologies supplied specialized scientific products and related services to support federal agencies'...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $82,231.05 firm fixed-price purchase order by the Food and Drug Administration on August 15, 2022, for an Automated Express Nucleic Acid Extraction System (Part # 4467754). The contract was awarded without set-aside designation and has an ultimate completion date of October 14, 2027. The system will be delivered to the FDA's facility in Grand Island, New York. This award supports the FDA's regulatory...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific headquartered in Grand Island, New York, was awarded a firm fixed-price purchase order valued at $4,707.50 on July 15, 2009, for a Countess Automated Cell Counter with an ultimate completion date of July 31, 2009. This non-set-aside contract represents a direct procurement of specialized laboratory equipment used in biomedical research and cell analysis applications. The place of performance was Grand Island, New York, where...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. and headquartered in Grand Island, New York, received a purchase order contract award from the Central Program Planning Coordination and Support office on January 27, 2015. This firm fixed-price contract, valued at $16,473.60 with an ultimate completion date of April 30, 2015, represents a non-set-aside award to the company's specialized biomedical research capabilities. As a leading provider of genetic analysis...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a firm fixed-price purchase order by a civilian federal agency (Pacific West Area) on March 23, 2016, with an ultimate completion date of April 8, 2016. The contract, valued at $3,753.00, covers the procurement of Capillary Array 48 x 50cm units (SKU 4331250). Life Technologies Corporation, headquartered in Grand Island, New York, is a leading supplier of biomedical research and genetic analysis tools to...
- This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and...
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a firm fixed-price purchase order by a civilian federal agency's Northeast Area on January 29, 2015, with a ceiling value of $3,822.76 and an ultimate completion date of December 31, 2015. The contract was awarded without a set-aside designation to the Carlsbad, California-based vendor. As a prominent manufacturer of scientific instruments, reagents, and consumables, Life Technologies Corporation supplies...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a firm fixed-price purchase order from a civilian Northeast Area federal agency on December 17, 2012, with a contract ceiling value of $36,629.60. The contract, which was not issued under a set-aside designation, is scheduled for completion by December 31, 2015, with performance conducted at the contractor's Carlsbad, California facility. As a leading manufacturer of scientific instruments, reagents, and...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $94,710.82 firm fixed-price purchase order by a civilian federal agency under the Pacific West Area on April 4, 2017, for a flow cytometer system. The contract, which required completion by April 29, 2017, represents a non-set-aside procurement reflecting Life Technologies' specialized technological capabilities in biomedical research instrumentation. The place of performance is Grand Island, New York,...
Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $11,903 firm fixed-price purchase order by the Food and Drug Administration on July 14, 2021, for automated cell counters and light cubes. The contract, which is not set-aside designated, has a completion date of December 31, 2021, and specifies performance in Grand Island, New York, where Life Technologies maintains its headquarters. As a leading provider of biomedical research and genetic analysis tools, Life Technologies supplies specialized scientific instruments and laboratory equipment to support the FDA's regulatory testing, research, and public health missions. This purchase order represents a routine procurement of laboratory instrumentation and consumables consistent with Life Technologies' core business supporting federal agencies including the FDA, National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. The company maintains an extensive federal contracting presence through multiple indefinite delivery vehicles and blanket purchase agreements that enable agencies to efficiently procure specialized genomic testing supplies, sequencing reagents, and laboratory equipment on an as-needed basis while maintaining cost certainty through firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 7/14/21 |